Sterben wie ein Hund? Konvergenzen und Divergenzen im human- und veterinärmedizinethischen Diskurs zum Lebensende von Menschen bzw. Heimtieren und Folgen für die Verhältnisbestimmung von Medizin- und Tierethik
Most recently, the lab was also able to establish scalable hematopoietic differentiation systems for human iPSC, which are able to continuously produce a multitude of hematopoietic cells. Thus, in close c
von Vγ9Vδ2 T Zellen: Vergleich von Mensch und Kameliden (Prof. Dr. Thomas Herrmann) Plastizität humaner gamma/delta T-Zellen: (Epigenetische) Modulation durch Vitamin C (Prof. Dr. Dietrich Kabelitz) U
Plastische, Ästhetische, Hand- und Wiederherstellungschirurgie Studium 2006 - 2012 Studium der Humanmedizin an der Medizinischen Hochschule Hannover Beruflicher Werdegang 2001 - 2004 Berufsausbildung mit
Kispert A, von Wasielewski R, Brabant G: Identification of a Wnt/beta catenin signaling pathway in human thyroid cells. Endocrinology 2001; 142(12): 5261-6 Hogemann D, Flemming P, Kreipe H, Galanski M: [...] 40(19): 7-14 Pötter E, Braun S, Lehmann U, Brabant G: Molecular cloning of a functional promoter of the human plakoglobin gene. Eur J Endocrinol 2001; 145(5): 625-33 Roth-Eichhorn S, Heitmann B, Flemming P, Kubicka [...] Evidence for the decreased expression of the latent TGF-beta binding protein and its splice form in human liver tumors. Scand J Gastroentero 2001; 36(11): 1204-10 Wellmann A, Flemming P, Behrens P, Wuppermann
interactions of Herpes Simplex Virus Type 1 (HSV-1) in cell types that it also interacts with in the human host: epithelial cells, neurons and immune cells. Towards this end, we investigate the virus-host [...] Medical School, College of Physicians & Surgeons, New York, USA working on integrin receptors of human neutrophils. For her PhD project in cell biology (1989-93), she moved to the European Molecular Biology [...] (2003-2009) Tanja Bosse - Dr. rer. nat., Postdoctoral Scientist (2007 - 2009) Sandra Rittweger – Human biology Diploma Student (2008 - 2009) Janus, Jessica - Dr. rer. nat., Predoctoral Scientist (2005-2009)
lernen und zum Ziel innovativer Behandlungsstrategien machen. Dafür verwenden wir in vielen Projekten humane induzierte pluripotente Stammzellen (iPS-Zellen), um patientenspezifische Stammzellen zur Verfügung [...] Advena-Regnery B, Dederer HG, Enghofer F, Cantz T , Heinemann T. Framing the ethical and legal issues of human artificial gametes in research, therapy, and assisted reproduction: A German perspective (2018). Bioethics [...] Dai Z, Zweigerdt R, Sharma AD, Ott M, Cantz T (2017). A scalable approach for the generation of human pluripotent stem cell-derived hepatic organoids with sensitive hepatotoxicity features. Stem Cells
inhibition of human myosin-6. FEBS Lett. 2012 Sep 21;586(19):3208-14. doi: 10.1016/j.febslet.2012.07.014. Epub 2012 Jul 31. Heissler SM, Manstein DJ (2012) Functional characterization of the human myosin-7a [...] of print] Schadzek P, Stahl Y, Preller M, Ngezahayo A. Analysis of the dominant mutation N188T of human connexin46 (hCx46) using concatenation and molecular dynamics simulation. (2019) FEBS Open Bio . 9 [...] Hardeman EC, Gunning PW. Co-polymers of Actin and Tropomyosin Account for a Major Fraction of the Human Actin Cytoskeleton. (2018) Curr Biol . 28 (14):2331-2337.e5. doi: 10.1016/j.cub.2018.05.053. Engelhard
and small-molecule inhibition of human myosin-6. FEBS Lett., doi: 10.1016/j.febslet.2012.07.014 Heissler SM, Manstein, D.J. (2012) Functional characterization of the human myosin-7a motor domain. Cell Mol [...] L., Fedorov, R., Henn, A., Taft, M. H., and Manstein, D.J. (2020) Mechanochemical properties of human myosin 1C are modulated by isoform-specific differences in the N-terminal extension. J Biol Chem. [...] and Gunning, P.W. (2018) Co-polymers of actin and tropomyosin account for a major fraction of the human actin cytoskeleton. Current Biology. doi: 10.1016/j.cub.2018.05.053 Pathan-Chhatbar, S., Taft, M.H
2004 - 2011 Studium der Humanmedizin an der Philipps-Universität zu Marburg 2011 Approbation als Ärztin 2011 - 2013 Assistenzärztin am Institut für Pathologie des Universitätsklinikums Ulm, Direktor: Prof